Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma: clinical, histological and cell biological evaluation
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier BV in Research in Virology
- Vol. 145, 261-269
- https://doi.org/10.1016/s0923-2516(07)80031-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Ultrasound as a tool to evaluate remission of cutaneous Kaposiʼs sarcomaAIDS, 1993
- Measurement of doxorubicin-induced lipid peroxidation under the conditions that determine cytotoxicity in cultured tumor cellsAnalytical Biochemistry, 1992
- Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Kaposi's sarcomaClinics in Dermatology, 1991
- A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin.Journal of Clinical Oncology, 1990
- Studies on the myelosuppressive activity of doxorubicin entrapped in liposomesCancer Chemotherapy and Pharmacology, 1990
- Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.Journal of Clinical Oncology, 1989
- Cultured, aids‐related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitroInternational Journal of Cancer, 1988
- The Natural History of Kaposi's Sarcoma in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985
- Prevalence of Kaposi's Sarcoma among Patients with AIDSThe New England Journal of Medicine, 1985